Efficacy of Bevacizumab Against Interface Neovascularization After Deep Anterior Lamellar Keratoplasty
Authors:
- Elena JarrínEJElena Jarrín
- Diego Ruiz-CasasDRDiego Ruiz-Casas
- Antonio MendivilAMAntonio Mendivil
- 1 February 2012
- journal article
- case report
- Published by Wolters Kluwer Health in Cornea
- Vol. 31 (2) , 188-190
Abstract
We report a case of neovascularization at the interface after a deep anterior lamellar keratoplasty and its regression after a single bevacizumab injection. Case report. We present a case of neovascularization and bleeding at the interface 2 days after a deep anterior lamellar keratoplasty for herpetic disease that was completely reversed by a single injection of bevacizumab at the interface. Corneal neovascularization is a typical sign of herpetic disease and one of the most important risk factors that can contribute to corneal graft failure. Close follow-up of patients at risk is necessary to detect and treat this complication as soon as possible to achieve a good outcome. Bevacizumab seems to be a successful and safe therapeutic option.Keywords
This publication has 23 references indexed in Scilit:
- Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked studyBMJ, 2010
- Herpes Simplex Virus KeratitisOphthalmology, 2009
- Topical Bevacizumab in the Treatment of Corneal NeovascularizationArchives of Ophthalmology (1950), 2009
- Feasibility Study of Lamellar Keratoplasty in a Murine ModelOcular Immunology and Inflammation, 2009
- Bevacizumab (Avastin) and Argon Laser to Treat Neovascularization in Corneal Transplant SurgeryCornea, 2008
- The Effect of Topical Bevacizumab on Corneal NeovascularizationOphthalmology, 2008
- Characteristics and Outcomes of Adult Patients Lost to Follow-Up at an Antiretroviral Treatment Clinic in Johannesburg, South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Bevacizumab for Graft RejectionOphthalmology, 2007
- Intralamellar haemorrhage 44 years following lamellar keratoplastyEye, 2005
- Immunosuppression with Cyclosporine A and Mycophenolate Mofetil After Penetrating High-Risk Keratoplasty: A Retrospective StudyTransplantation, 2005